==== Front Skin Res Technol Skin Res Technol 10.1111/(ISSN)1600-0846 SRT Skin Research and Technology 0909-752X 1600-0846 John Wiley and Sons Inc. Hoboken 10.1111/srt.13401 SRT13401 Original Article Original Articles Impact of blue light on skin pigmentation in patients with melasma LI et al. Li Lingjia 1 2 Jiang Xin 2 Tu Yin 2 Yang Yaqi 2 Zhang Xin 2 Gu Hua 2 guhua1978@sina.com He Li https://orcid.org/0000-0002-3601-3036 2 drheli2662@126.com 1 Department of Dermatology Jiangnan University Medical Center, Jiangnan University Jiangsu China 2 Department of Dermatology The First Affiliated Hospital of Kunming Medical University Kunming Medical University Yunnan China * Correspondence Hua Gu , Department of Dermatology, The First Affiliated Hospital of Kunming Medical University, Kunming Medical University, Yunnan, China. Emails: guhua1978@sina.com 02 7 2023 7 2023 29 7 10.1111/srt.v29.7 e1340109 3 2023 19 6 2023 © 2023 The Authors. Skin Research and Technology published by John Wiley & Sons Ltd. https://creativecommons.org/licenses/by/4.0/ This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. Abstract Background The difference in skin pigmentation induced by blue light between melasma patients and healthy people has not been reported. This study aimed to explore the impact of different doses of blue light irradiation on the pigmentation of the skin of non‐exposed areas in female melasma patients with III‐IV‐type skin and healthy women. Materials and methods This observational study enrolled patients with melasma and healthy people at the First Affiliated Hospital of Kunming Medical University between January and April 2021. The outcomes were the degree of pigmentation, ΔL*, and ΔITA* values. Results Forty‐two (21/group) participants were enrolled. After irradiation with different doses of blue light, different degrees of pigmentation could be observed in the irradiated area of the skin of female melasma patients and healthy women. The △L* and △ITA* values in the irradiated area of the skin of healthy women were higher than in female melasma patients after blue light irradiation at 20 J/cm2 (p < 0.05). There were no significant differences in the pigmentation scores, △L* values, and △ITA* values in the irradiated areas of skin at different time points after irradiation with the other doses of blue light (p > 0.05). Conclusion Blue light at 20 J/cm2 induced a smaller change in pigmentation in melasma patients than in healthy women, but the effect of blue light at 40–80 J/cm2 was similar. healthy individuals melasma observational study skin pigmentation visible light Yunnan Clinical Medical Center for Skin and Immune DiseasesZX2019‐03‐02 source-schema-version-number2.0 cover-dateJuly 2023 details-of-publishers-convertorConverter:WILEY_ML3GV2_TO_JATSPMC version:6.3.0 mode:remove_FC converted:02.07.2023 Li L , Jiang X , Tu Y , et al. Impact of blue light on skin pigmentation in patients with melasma. Skin Res Technol. 2023;29 :e13401. 10.1111/srt.13401 Lingjia Li and Xin Jiang contributed equally to this work. ==== Body pmc1 INTRODUCTION Melasma is a common acquired skin pigmentation disease characterized by light‐brown to dark‐brown pigmented spots on the exposed areas of the face, such as the forehead, cheeks, and lower jaw, and is more common in darker‐skin III‐IV‐type Asian or Hispanic women. 1 , 2 , 3 , 4 The pathogenesis of melasma is not yet clear, and it is believed to be mostly related to solar radiation, genetics, and sex hormone levels. 2 , 5 , 6 , 7 Solar radiation is one of the important causes of melasma. 1 Melasma may be associated with photoaging and solar elastosis and tends to be a chronic condition after treatment. 2 , 3 Sunlight is divided into extreme ultraviolet (UV) rays, UV rays, visible light, and infrared rays according to the different wavelengths. 8 UV irradiation can induce melanin synthesis, cause pigmentation in the irradiated area, and induce pigmentation diseases, including melasma. 1 , 9 Visible light (400–700 nm) accounts for about 50% of solar radiation. 10 Visible light, particularly high‐energy visible light (400–500 nm), also called blue light, participates in skin aging. 11 , 12 Blue light can cause skin hyperpigmentation, particularly in dark‐skinned people. 13 The degree of pigmentation is more obvious than the pigmentation induced by UV rays, and the blue light‐induced pigmentation can last as long as 3 months. 13 , 14 Blue light can induce immediate melanosis, continuous melanosis, and delayed melanosis. 13 , 14 These effects can be observed in all skin types, including in patients with pigmentation diseases. 10 , 15 The reason for this effect of blue light is that melanocyte opsin 3 activates calmodulin‐dependent protein kinase II, transcription factor cAMP‐responsive element‐binding protein, mitogen‐activated protein kinase P38, and extracellular regulated protein kinase by sensing external blue light and induces melanin synthesis. 16 In ex vivo skin specimens, gene expression and tyrosinase activity are increased by visible light. 17 Persistent pigment darkening could last up to 10 days when repeated exposures were performed, but pigmentation faded after 24 h when a single exposure was used. 17 Visible light also has effects on the skin barrier function. 18 It could be hypothesized that healthy people will have a more serious degree of melanosis after exposure to blue light than normal people because of lower baseline melanosis. Therefore, this study aimed to explore the impact of blue light irradiation on the pigmentation in the skin of non‐exposed areas in female melasma patients with III‐IV‐type skin and healthy women. 2 MATERIALS AND METHODS 2.1 Study design and population This observational study included patients with melasma and healthy people at the First Affiliated Hospital of Kunming Medical University between January and April 2021. This study was approved by the Ethics Committee of the First Affiliated Hospital of Kunming Medical University. Informed consent was obtained from all subjects, and the informed consent form was signed. This study was performed following the tenets of the Declaration of Helsinki. The inclusion criteria were 1) diagnosis of melasma, 2) 20–50 years old, 3) not pregnant or breastfeeding, 4) living in Yunnan for ≥3 years, and 5) no folliculitis, atopic dermatitis, port‐wine stains, etc., in the irradiated area that could affect the assessments in the irradiated area. The exclusion criteria were 1) pigmentation diseases on the face, 2) history of immune system diseases, photosensitivity diseases, inflammatory skin diseases, or major organ diseases, or 3) having taken photosensitive drugs recently. For the healthy women group, age‐matched individuals were selected. The selection criteria were the same as for the patients, except for the melasma diagnosis. 2.2 Procedure Blue light with a wavelength of 400–520 nm was produced by a blue light irradiator (Sellamed VIS 400, Sellas, Germany). The average blue light irradiance intensity at a distance of 10 cm from the light source was measured using a blue light radiometer (FL‐1D, Beijing Normal University Photoelectric Instrument Factory, Beijing, China) and was 50 mW/cm2. A 1‐cm‐thick thermal insulation PVC board was used to make a cuboid mold with a length of 32.6 cm, a width of 24.6 cm, and a height of 10 cm. The inside was painted black. There were two rows of irradiation holes on the front, 4 cm from top to bottom and 3 cm from left to right, and there were two square irradiating holes with an area of 1 cm2 in each row. All participants were exposed to blue light irradiation, with the back slightly touching the surface of the mold. Blue light at 20, 40, 60, and 80 J/cm2 was used to irradiate the skin on the back of the participants. The irradiated areas were photographed at 0 h, 24 h, 1 week, and 2 weeks after irradiation. 2.3 Outcomes The pigmentation degree in the irradiated area was assessed according to the Investigator's Global Assessment Scale (IGAS) (Table S1). 19 The irradiation intensity of the blue light machine was 50 ± 5 mW/cm2. After irradiation, the irradiation site was marked. The values were measured at the same irradiation site at different time points, and then the IGAS was calculated. A portable spectrophotometer (CM‐2600d; Konica Minolta, Japan) was used to measure the L* values and b* values of the irradiated and non‐irradiated areas at 0 h, 24 h, 1 week, and 2 weeks after irradiation, and the corresponding ΔL* value and ΔITA value were calculated. The L* value represents brightness. ΔL* value = L* value of irradiated area‐ L* value of non‐irradiated area. The larger the ΔL* value is, the more obvious the pigmentation is. ITA value = [arctan(L*−50)/b*]x180/π. ΔITA value = ITA value at the irradiated area‐ ITA value at the non‐irradiated area. The larger the ΔITA value is, the more obvious the pigmentation is. 19 , 20 2.4 Statistical analysis SPSS 26.0 (IBM Corp., Armonk, NY, USA) was used for data analysis. The continuous data were presented as means ± standard deviation and analyzed using repeated‐measures ANOVA to compare the data within a given group among time points and Student's t‐test to compare groups. p < 0.05 was statistically significant. 3 RESULTS Forty‐two (21/group) female patients with melasma and healthy women (all with III‐IV skin phototype and living in Yunnan) were enrolled. There were no differences in age (35.4 ± 1.9 vs. 35.8 ± 1.9 years, p = 0.83), L* (65.46 ± 3.01 vs. 63.82 ± 4.02, p = 0.15), and ITA (32.36 ± 6.87 vs. 28.66 ± 9.34, p = 0.17) between the two groups (Table 1). TABLE 1 Baseline characteristics of melasma patients and healthy women. Melasma patients (n = 21) Healthy women (n = 21) p Age 35.76 ± 8.84 35.38 ± 8.71 0.83 L* 65.46 ± 3.01 63.82 ± 4.02 0.15 ITA 32.36 ± 6.87 28.66 ± 9.34 0.17 John Wiley & Sons, Ltd. Blue light irradiation of 20, 40, 60, and 80 J/cm2 could induce different degrees of pigmentation in the skin on the back of melasma patients and healthy women, and the degree of pigmentation was dose‐dependent. A dose as low as 20 J/cm2 of blue light irradiation could induce pigmentation in the skin of melasma patients and healthy women, which did not completely subside after 2 weeks. In addition, it was also observed that after blue light irradiation, transient erythema also appeared in the irradiated area, which subsided within 24 h (Figure 1). FIGURE 1 (Upper panel) Pigmentation in the skin on the back of melasma patients induced by blue light at (a) 0 h, (b) 24 h, (c) 1 week, and (d) 2 weeks. (Bottom panel) Pigmentation in the skin on the back of healthy women was induced by blue light at (e) 0 h, (f) 24 h, (g) 1 week, and (h) 2 weeks. The blue arrows indicate transient erythema. The IGA scores on the skin of the non‐exposed areas in the melasma patient and healthy women groups at 0 h of irradiation of blue light at 20, 40, 60, and 80 J/cm2 were higher than those at 24 h, 1 week, and 2 weeks. The IGAS were not significantly different between the two groups, and there were no time effects after 20, 49, and 80 J/cm2 blue light irradiation were all lower than those of the healthy women group, but the melasma patients had higher IGAS after 60 J/cm2 blue light irradiation, with significant changes in time, but no time × group interaction was observed (Figure S1 and Table 2). TABLE 2 Pigmentation IGA scores of the skin in the irradiated areas in the melasma patient and healthy women groups at different time points. Blue light intensity Time Melasma patients (n = 21) Healthy women (n = 21) P Time P Group P Interaction 20 J/cm2 0 h 0.83 ± 0.09 0.98 ± 0.16 ref 0.068 0.503 24 h 0.67 ± 0.09 0.81 ± 0.11 0.232 0.209 1 week 0.64 ± 0.10 0.83 ± 0.14 0.227 0.282 2 weeks 0.67 ± 0.11 0.81 ± 0.13 0.254 0.480 40 J/cm2 0 h 2.05 ± 0.22 1.67 ± 0.22 ref 0.073 0.233 24 h 1.69 ± 0.17 1.40 ± 0.14 0.079 0.300 1 week 1.55 ± 0.15 1.50 ± 0.15 0.073 0.801 2 weeks 1.67 ± 0.17 1.40 ± 0.16 0.096 0.304 60 J/cm2 0 h 2.74 ± 0.24 2.14 ± 0.24 ref 0.023 0.055 24 h 2.00 ± 0.15 1.90 ± 0.17 0.02 0.531 1 week 2.00 ± 0.15 1.90 ± 0.16 0.018 0.328 2 weeks 2.05 ± 0.18 1.83 ± 0.20 0.025 0.424 80 J/cm2 0 h 2.88 ± 0.32 2.29 ± 0.26 ref 0.240 0.219 24 h 2.12 ± 0.18 2.07 ± 0.16 0.120 0.896 1 week 2.14 ± 0.23 1.98 ± 0.18 0.109 0.571 2 weeks 2.12 ± 0.24 1.95 ± 0.19 0.085 0.582 John Wiley & Sons, Ltd. The mean values of ΔL* and ΔITA* on the skin of the non‐exposed areas in the melasma patient and healthy women groups at 0 h with 20, 40, 60, and 80 J/cm2 blue light irradiation were higher than those at 24 h, 1 week, and 2 weeks (all p < 0.01). The mean values of ΔL* and ΔITA* of the melasma patient group at different time points were lower than those of the healthy women group after 20 J/cm2 blue light irradiation (all p > 0.05) (Figures S2 and S3 and Table 3). TABLE 3 △L* and △ITA values at different time points. Indicators Blue light intensity Time Melasma patients (n = 21) Healthy women (n = 21) P Time P Group P Interaction △L* 20 J/cm2 0 h −7.40 ± 0.75 −8.11 ± 0.93 ref 0.029 0.558 24 h −4.77 ± 0.51 −5.94 ± 0.63 0.001 0.166 1 week −4.08 ± 0.53 −5.52 ± 0.75 <0.001 0.187 2 weeks −3.66 ± 0.49 −5.65 ± 0.71 <0.001 0.038 40 J/cm2 0 h −10.55 ± 0.86 −10.93 ± 0.97 ref 0.574 0.772 24 h −7.22 ± 0.61 −7.24 ± 0.69 <0.001 0.980 1 week −6.32 ± 0.69 −6.96 ± 0.67 <0.001 0.538 2 weeks −6.01 ± 0.73 −6.81 ± 0.67 <0.001 0.474 60 J/cm2 0 h −11.55 ± 0.65 −12.16 ± 0.83 ref 0.603 0.564 24 h −7.82 ± 0.66 −7.66 ± 0.67 <0.001 0.867 1 week −6.94 ± 0.73 −7.63 ± 0.81 <0.001 0.526 2 weeks −6.26 ± 0.58 −7.34 ± 0.75 <0.001 0.660 80 J/cm2 0 h −12.04 ± 0.95 −12.07 ± 1.07 ref 0.445 0.980 24 h −8.25 ± 0.73 −8.77 ± 0.83 <0.001 0.638 1 week −6.96 ± 0.67 −7.79 ± 0.80 <0.001 0.431 2 weeks −6.85 ± 0.71 −7.72 ± 0.79 <0.001 0.418 △ITA* 20 J/cm2 0 h −13.66 ± 1.93 −14.29 ± 2.19 ref 0.033 0.833 24 h −7.75 ± 1.16 −10.33 ± 1.47 0.006 0.176 1 week −7.56 ± 1.16 −10.86 ± 1.52 0.008 0.148 2 weeks −7.24 ± 1.10 −11.12 ± 1.43 0.007 0.037 40 J/cm2 0 h −20.39 ± 2.19 −20.87 ± 2.41 ref 0.574 0.881 24 h −12.82 ± 1.41 −13.48 ± 1.53 <0.001 0.752 1 week −12.45 ± 1.45 −14.05 ± 1.38 <0.001 0.538 2 weeks −12.32 ± 1.57 −13.84 ± 1.35 <0.001 0.468 60 J/cm2 0 h −22.62 ± 1.74 −23.64 ± 2.02 ref 0.509 0.705 24 h −14.05 ± 1.53 −14.36 ± 1.42 <0.001 0.880 1 week −13.68 ± 1.60 −15.31 ± 1.71 <0.001 0.492 2 weeks −12.48 ± 1.40 −14.71 ± 1.51 <0.001 0.642 80 J/cm2 0 h −23.76 ± 2.51 −23.58 ± 2.71 ref 0.426 0.961 24 h −14.86 ± 1.73 −16.37 ± 1.96 0.001 0.567 1 week −13.69 ± 1.42 −15.99 ± 1.66 <0.001 0.300 2 weeks −13.46 ± 1.66 −15.86 ± 1.98 <0.001 0.303 John Wiley & Sons, Ltd. 4 DISCUSSION This study suggested that blue light at 20 J/cm2 induced a smaller change in pigmentation in melasma patients than in healthy women, but the effect of blue light at 40, 60, and 80 J/cm2 was similar. Consistent with previous reports, in the present study, blue light could induce pigmentation in III‐IV‐type skin, and the degree of pigmentation was dose‐dependent. 11 , 12 , 13 The reason is that opsin 3 in melanocytes senses the stimulation from external blue light, induces an increase in melanin synthesis through a series of signaling cascades pathways, and blue light can also induce melanocytes in type III and IV skin to form the tyrosinase and dopa isomerase protein complex, which ultimately leads to the formation of long‐lasting pigmentation. 13 , 16 Different from Mahmoud et al., 14 it was observed in this study that 20‐J/cm2 blue light irradiation could induce obvious pigmentation in III‐IV‐type skin, and it lasted for a long time, suggesting that blue light within the visible light is the main light source to induce skin pigmentation, even at low levels. In addition, a transient erythematous reaction was also observed in the irradiated area, which could be caused by skin telangiectasis caused by the photothermal effect. 13 , 14 In the present study, the changes in L* in ITA* were smaller in melasma patients than in healthy individuals, suggesting that the baseline skin pigmentation mechanisms were already active and that low‐dose blue light (20 J/cm2) had a small activating effect. Supporting these results, Duteil et al. 21 reported that short‐term repeated exposure to blue light irradiation from electronic devices in melasma patients did not deepen the pigmentation of skin lesions, suggesting that repeated low‐dose blue light irradiation has a limited effect on the pigmentation of the skin in melasma patients; it could be hypothesized that the activating effect of blue light from electronic devices is below the baseline melanosis level in melasma patients. On the other hand, higher doses of blue light (40, 60, and 80 J/cm2) had similar effects in patients with melasma and healthy controls. In this study, melasma patients and healthy women were exposed to a single dose of 20–80 J/cm2 blue light irradiation, and there were no significant differences in the IGAS at the irradiation area between groups, suggesting that melasma patients have similar sensitivity to pigmentation induced by blue light than healthy women, that is, a single small‐dose of blue light irradiation has limited effects on melasma patients. Blue light can induce immediate melanosis, continuous melanosis, and delayed melanosis. 13 , 14 In the present study, melanosis was immediate in both groups and was continuous over 2 weeks, but no increase or flare‐up in melanosis was observed, indicating the absence of delayed melanosis, at least over 2 weeks. Still, this study did not examine the effect of repeated or long‐duration exposures. Indeed, people working all day long with computers are continuously exposed to blue light several hours a day in addition to the exposure from smartphones and tablets. Besides occupational exposure, blue light in daily life mainly comes from sunlight. The solar radiation intensity on the earth's surface is 440 W/m2; the blue light energy accounts for one‐fifth of the visible light, and the blue light radiation intensity is about 8.8 mW/cm2. 13 In the present study, a blue light radiometer was used to continuously measure the blue light irradiation intensity at local noontime for 1 week. The average blue light irradiation intensity was 8.1 mW/cm2, and the 20–80 J/cm2 blue light irradiation dose is equivalent to sunlight exposure for 42–165 min. Therefore, it suggests that the blue light irradiation dose accumulated during a sunlight exposure of < 165 min does not aggravate pigmentation in melasma patients. Nevertheless, in addition to blue light, sunlight also includes ultraviolet rays, which can synergistically induce pigmentation, and broad‐spectrum sunscreens that protect against ultraviolet rays and blue light can effectively reduce the recurrence rate of melasma patients. 19 , 22 Therefore, we recommend that melasma patients still take appropriate sun protection measures, including umbrellas, wearing long clothes, and using broad‐spectrum sunscreens. Besides melanosis, blue light also induces oxidative stress in the skin. A study showed that irradiation of keratinocytes with 41.35 J/cm2 of blue light at 453 nm wavelength induced an increase in reactive oxygen species (ROS) as early as within 1 h after exposure. 23 The mechanisms involve the photoreduction of intracellular flavins and the subsequent production of ROS. 24 , 25 These ROS can induce the release of pro‐inflammatory mediators in the skin. 26 Still, the results among studies are inconsistent and appear to be dependent upon the wavelength used 26 , 27 , 28 ; whether natural blue light exerts pro‐oxidative and pro‐inflammatory effects remains to be examined. Furthermore, whether antioxidant supplements and sunscreens could prevent those pro‐oxidative and pro‐inflammatory effects in response to blue light should be explored. This study has limitations. The participants were from a single center, and the sample size was small. Therefore, stratification based on skin phototype could not be performed. Only females were included, and whether males could show similar effects (because of differences in hormones) is unknown. Even if dose equivalence was calculated, the 80 J/cm2 dose, for example, was given within a much shorter time than 165 min, which could induce reactions that would not be observed in real life. 5 CONCLUSION In conclusion, blue light at 20 J/cm2 induced a smaller change in pigmentation in melasma patients than in healthy women, but the effect of blue light at 40, 60, and 80 J/cm2 was similar. The effect of blue light irradiation lasted for 2 weeks in melasma patients and healthy individuals. These results may guide evidence‐based sun protection strategies in patients with melasma and have implications in the context of electronic device use. These results call for enhancing the general population's awareness of blue light and UV protection. CONFLICT OF INTEREST STATEMENT The authors declare no conflict of interest. ETHICS STATEMENT This study was reviewed by the Ethics Committee of the First Affiliated Hospital of Kunming Medical University. Informed consent was obtained from all subjects, and the informed consent form was signed. Supporting information Supporting Information Click here for additional data file. Supporting Information. Click here for additional data file. Supporting Information. Click here for additional data file. Supporting Information. Click here for additional data file. ACKNOWLEDGMENTS The authors have nothing to report. DATA AVAILABILITY STATEMENT All data generated or analyzed during this study are included in this published article/as supplementary information files. ==== Refs REFERENCES 1 Rajanala S , Maymone MBC , Vashi NA . Melasma pathogenesis: a review of the latest research, pathological findings, and investigational therapies. Dermatol Online J. 2019;25 (10 ):13030. 2 Sheth VM , Pandya AG . Melasma: a comprehensive update: part I. J Am Acad Dermatol. 2011;65 :689‐697.21920241 3 McKesey J , Tovar‐Garza A , Pandya AG . Melasma treatment: an evidence‐based review. Am J Clin Dermatol. 2020;21 :173‐225.31802394 4 Sarkar R , Gokhale N , Godse K , et al. Medical management of melasma: a review with consensus recommendations by Indian Pigmentary Expert Group. Indian J Dermatol. 2017;62 :558‐577.29263529 5 Ortonne JP , Arellano I , Berneburg M , et al. A global survey of the role of ultraviolet radiation and hormonal influences in the development of melasma. J Eur Acad Dermatol Venereol. 2009;23 :1254‐1262.19486232 6 Tamega Ade A , Miot LD , Bonfietti C , Gige TC , Marques ME , Miot HA . Clinical patterns and epidemiological characteristics of facial melasma in Brazilian women. J Eur Acad Dermatol Venereol. 2013;27 :151‐156.22212073 7 Lee AY . Recent progress in melasma pathogenesis. Pigment Cell Melanoma Res. 2015;28 :648‐660.26230865 8 Austin E , Geisler AN , Nguyen J , et al. Visible light. Part I: Properties and cutaneous effects of visible light. J Am Acad Dermatol. 2021;84 :1219‐1231.33640508 9 Kang WH , Yoon KH , Lee ES , et al. Melasma: histopathological characteristics in 56 Korean patients. Br J Dermatol. 2002;146 :228‐237.11903232 10 Campiche R , Curpen SJ , Lutchmanen‐Kolanthan V , et al. Pigmentation effects of blue light irradiation on skin and how to protect against them. Int J Cosmet Sci. 2020;42 :399‐406.32478879 11 Mahmoud BH , Hexsel CL , Hamzavi IH , Lim HW . Effects of visible light on the skin. Photochem Photobiol. 2008;84 :450‐462.18248499 12 Sondenheimer K , Krutmann J . Novel Means for Photoprotection. Front Med. 2018;5 :162. 13 Duteil L , Cardot‐Leccia N , Queille‐Roussel C , et al. Differences in visible light‐induced pigmentation according to wavelengths: A clinical and histological study in comparison with UVB exposure. Pigment Cell Melanoma Res. 2014;27 :822‐826.24888214 14 Mahmoud BH , Ruvolo E , Hexsel CL , et al. Impact of long‐wavelength UVA and visible light on melanocompetent skin. J Invest Dermatol. 2010;130 :2092‐2097.20410914 15 Kleinpenning MM , Smits T , Frunt MH , van Erp PE , van de Kerkhof PC , Gerritsen RM . Clinical and histological effects of blue light on normal skin. Photodermatol Photoimmunol Photomed. 2010;26 :16‐21.20070834 16 Regazzetti C , Sormani L , Debayle D , et al. Melanocytes sense blue light and regulate pigmentation through opsin‐3. J Invest Dermatol. 2018;138 :171‐178.28842328 17 Randhawa M , Seo I , Liebel F , Southall MD , Kollias N , Ruvolo E . Visible light induces melanogenesis in human skin through a photoadaptive response. PLoS One. 2015;10 :e0130949.26121474 18 Lohan SB , Muller R , Albrecht S , et al. Free radicals induced by sunlight in different spectral regions ‐ in vivo versus ex vivo study. Exp Dermatol. 2016;25 :380‐385.26910569 19 Kohli I , Chaowattanapanit S , Mohammad TF , et al. Synergistic effects of long‐wavelength ultraviolet A1 and visible light on pigmentation and erythema. Br J Dermatol. 2018;178 :1173‐1180.28877342 20 Ly BCK , Dyer EB , Feig JL , Chien AL , Del Bino S . Research techniques made simple: cutaneous colorimetry: a reliable technique for objective skin color measurement. J Invest Dermatol. 2020;140 :3‐12.e1.e11.31864431 21 Duteil L , Queille‐Roussel C , Lacour JP , Montaudie H , Passeron T . Short‐term exposure to blue light emitted by electronic devices does not worsen melasma. J Am Acad Dermatol. 2020;83 :913‐914.31887321 22 Boukari F , Jourdan E , Fontas E , et al. Prevention of melasma relapses with sunscreen combining protection against UV and short wavelengths of visible light: a prospective randomized comparative trial. J Am Acad Dermatol. 2015;72 :189‐190.e1.e181.25443629 23 Becker A , Klapczynski A , Kuch N , et al. Gene expression profiling reveals aryl hydrocarbon receptor as a possible target for photobiomodulation when using blue light. Sci Rep. 2016;6 :33847.27669902 24 Hockberger PE , Skimina TA , Centonze VE , et al. Activation of flavin‐containing oxidases underlies light‐induced production of H2O2 in mammalian cells. Proc Natl Acad Sci U S A. 1999;96 :6255‐6260.10339574 25 Lewis JB , Wataha JC , Messer RL , Caughman GB , Yamamoto T , Hsu SD . Blue light differentially alters cellular redox properties. J Biomed Mater Res B Appl Biomater. 2005;72 :223‐229.15546154 26 Liebel F , Kaur S , Ruvolo E , Kollias N , Southall MD . Irradiation of skin with visible light induces reactive oxygen species and matrix‐degrading enzymes. J Invest Dermatol. 2012;132 :1901‐1907.22318388 27 Liebmann J , Born M , Kolb‐Bachofen V . Blue‐light irradiation regulates proliferation and differentiation in human skin cells. J Invest Dermatol. 2010;130 :259‐269.19675580 28 Mann T , Eggers K , Rippke F , et al. High‐energy visible light at ambient doses and intensities induces oxidative stress of skin‐Protective effects of the antioxidant and Nrf2 inducer Licochalcone A in vitro and in vivo. Photodermatol Photoimmunol Photomed. 2020;36 :135‐144.31661571